A 6‐month, open‐label study of memantine in patients with frontotemporal dementia

Abstract

The number of patients was small, so that the evidence given by statistical tests is limited. Thus, the present study can only show trends regarding drug effects. As memantine is well-tolerated, further randomized and controlled studies should be conducted to evaluate drug efficacy.